BackClene- Warrants (30/12/2025) Overview

Clene- Warrants (30/12/2025) Current Assets

Latest current assets for CLNNW: $13M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$13.02M
11.23% YoYΔ $-1.65M vs prior year quarter

Peer average / median

Loading

Clene- Warrants (30/12/2025) Current Assets History

Loading

Clene- Warrants (30/12/2025) vs. peers: Current Assets Comparison

Loading

Clene- Warrants (30/12/2025) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clene- Warrants (30/12/2025) (CLNNW) FAQ

The latest current assets for CLNNW is $13M as of March 2026. That compares with $15M in the prior-year period — down 11.2% year over year. Investors often review this figure alongside Clene- Warrants (30/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CLNNW's current assets moved from $15M to $13M — a 11.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clene- Warrants (30/12/2025)'s operating scale or balance-sheet position.

A current assets figure of $13M for CLNNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CLNNW's current assets ($13M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Clene- Warrants (30/12/2025)'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.